CIK 0001627281 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in I0 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-14 | 6-K | FORM 6-K | 2026-09-14 |
| 2026-09-11 | 6-K | FORM 6-K | 2026-09-11 |
| 2026-09-11 | 6-K/A | 6-K/A | 2026-06-30 |
| 2026-09-01 | 6-K | FORM 6-K | 2026-09-01 |
| 2026-08-06 | S-8 | S-8 | |
| 2026-08-06 | 6-K | FORM 6-K | 2026-08-06 |
| 2026-08-06 | 6-K | 6-K | 2026-08-06 |
| 2026-07-30 | 6-K | FORM 6-K | 2026-07-30 |
| 2026-06-26 | 6-K/A | 6-K/A | 2026-06-26 |
| 2026-06-25 | 6-K | FORM 6-K | 2026-06-25 |
| 2026-06-25 | 6-K | 6-K | 2026-06-25 |
| 2026-06-11 | 6-K | FORM 6-K | 2026-06-11 |
| 2026-06-09 | 6-K | FORM 6-K | 2026-06-09 |
| 2026-05-21 | 6-K | 6-K | 2026-05-20 |
| 2026-05-20 | 6-K | FORM 6-K | 2026-05-20 |
| 2026-05-12 | 6-K | FORM 6-K | 2026-05-12 |
| 2026-05-11 | 6-K | FORM 6-K | 2026-05-11 |
| 2026-05-11 | 6-K | 6-K | 2026-05-11 |
| 2026-05-04 | 6-K | FORM 6-K | 2026-05-04 |
| 2026-04-27 | 6-K | FORM 6-K | 2026-04-27 |
| 2026-04-13 | 6-K | FORM 6-K | 2026-04-13 |
| 2026-03-20 | 20-F | 20-F | 2025-12-31 |
| 2026-03-20 | 6-K | FORM 6-K | 2026-03-19 |
| 2026-03-12 | 6-K | FORM 6-K | 2026-03-12 |
| 2026-01-08 | 6-K | FORM 6-K | 2026-01-08 |
Forms on file (last 1,000): 6-K 387, SC 13G/A 16, SC 13D/A 12, 20-F 11, S-8 10, SC 13G 10, 6-K/A 9, UPLOAD 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CLLS (0.002 USD), /gw/filings/filings?ticker=CLLS&form=8-K, /gw/filings/facts?ticker=CLLS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange